about
Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership.Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.Microenvironmental regulation of tumour angiogenesis.ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation.VEGFR2 regulates endothelial differentiation of colon cancer cells.The clinical utility of circulating tumour cells in patients with small cell lung cancer.Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.Progress and prospects of early detection in lung cancer.The role of Dickkopf family in cancers: from Bench to Bedside.Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors.Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin.3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry.Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer.Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry.Tumor heterogeneity in small cell lung cancer defined and investigated in pre-clinical mouse models.Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models.Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin.The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent mannerPolyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathwayOverview of advances in vasculogenic mimicry - a potential target for tumor therapy
P2860
Q39128280-9A690AB3-35F1-4140-9DD8-09CF14ECFFD8Q39188509-965A4D2D-B7B5-4CA8-BD5C-DA4E672DFCA3Q39433862-BD795662-E6FA-48D7-B1EF-2E38AA3165FCQ41512277-3705BA67-C76D-45F9-9252-35766C2C0801Q41570454-5B0BD7C4-3714-4FD6-A23F-3C3C6AEAC737Q41605002-92B9AA3C-B5BE-4229-85AE-F6AF46D8600FQ41605016-26B89AA2-3532-4EDC-99BA-242744BA9066Q42139806-04B6C6C8-D9A1-4EDB-95E6-7CBBF2353285Q42367897-D70D9D87-C284-4FDC-8F54-13436E0FB456Q42925962-4C31882A-6156-4E16-B7D1-8763CBA68BB4Q43792104-E0A6FADF-7581-42A2-BCD4-61B339DE9E61Q44277941-FCD277D4-1416-4D75-BF7A-64A895BFE478Q46171322-F3B72B2F-98AB-4220-ACDA-E97D2B59AC30Q47094540-0A147BEE-C79B-4519-B4B6-544A070F565AQ48049656-9B81E769-1123-404F-8FDA-0F1A9375C507Q50020376-F141C37F-59AD-4C1B-A9F9-23F3B6F9801AQ51731135-DC109998-72FF-43B8-A937-37B909D3831FQ52632722-125017FA-3E37-4CD6-B328-03BBADD13EE0Q53702193-311E38B6-3D7F-4AFB-9C2E-C7C1491ED57FQ55003664-CA4CB95E-ECA3-4F6F-8F16-6035226E4B1FQ55023971-453BAC84-A2D1-451D-B782-89A5E71A1235Q55363725-B80F4EE2-CE25-47F2-8478-BAAB66513D5AQ56119780-3DFCF1A6-E741-408C-A82A-A09C3B5CA919Q58763443-420778BD-550B-48A9-8705-BC9ABDF28DAEQ58803491-4F96290F-1BAF-461D-ACF5-CCC61FC6BF28
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Vasculogenic mimicry in small cell lung cancer.
@en
Vasculogenic mimicry in small cell lung cancer.
@nl
type
label
Vasculogenic mimicry in small cell lung cancer.
@en
Vasculogenic mimicry in small cell lung cancer.
@nl
prefLabel
Vasculogenic mimicry in small cell lung cancer.
@en
Vasculogenic mimicry in small cell lung cancer.
@nl
P2093
P2860
P50
P356
P1476
Vasculogenic mimicry in small cell lung cancer.
@en
P2093
Alberto Fusi
Anders Carlsson
Andrew Hughes
Christopher P E Chester
Daisuke Nonaka
Dominic G Rothwell
Elisabeth A Seftor
Francesca Trapani
Fredrika Carlsson
P2860
P2888
P356
10.1038/NCOMMS13322
P407
P577
2016-11-09T00:00:00Z